tiprankstipranks
Trending News
More News >
Immunic (IMUX)
NASDAQ:IMUX
US Market

Immunic (IMUX) Income Statement

Compare
2,011 Followers

Immunic Income Statement

Last quarter (Q3 2025), Immunic's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Immunic's net income was $-25.58M. See Immunic’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -111.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 98.05M$ 99.22M$ 119.49M$ 91.67M$ 48.97M
Depreciation and Amortization
$ 134.00K$ 111.00K$ 77.00K$ 85.00K$ 39.00K
EBITDA
$ -97.92M$ -99.11M$ -86.44M$ -91.58M$ -48.93M
Operating Income
$ -98.05M$ -99.22M$ -119.49M$ -91.67M$ -48.97M
Other Income/Expenses
$ -2.46M$ 5.61M$ -919.00K$ -1.28M$ 4.95M
Pretax Income
$ -100.51M$ -93.61M$ -120.41M$ -92.94M$ -44.02M
Net Income
$ -100.51M$ -93.61M$ -120.41M$ -92.94M$ -44.02M
Per Share Metrics
Basic EPS
$ -1.00$ -2.11$ -3.78$ -3.92$ -2.81
Diluted EPS
$ -1.00$ -2.11$ -3.78$ -3.92$ -2.81
Weighted Average Shares Outstanding
100.17M 44.32M 31.82M 23.65M 15.66M
Weighted Average Shares Outstanding (Diluted)
100.17M 44.32M 31.82M 23.65M 15.66M
Currency in USD

Immunic Earnings and Revenue History